328 related articles for article (PubMed ID: 35314680)
1. Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion.
Jiang N; Xie B; Xiao W; Fan M; Xu S; Duan Y; Hamsafar Y; Evans AC; Huang J; Zhou W; Lin X; Ye N; Wanggou S; Chen W; Jing D; Fragoso RC; Dugger BN; Wilson PF; Coleman MA; Xia S; Li X; Sun LQ; Monjazeb AM; Wang A; Murphy WJ; Kung HJ; Lam KS; Chen HW; Li JJ
Nat Commun; 2022 Mar; 13(1):1511. PubMed ID: 35314680
[TBL] [Abstract][Full Text] [Related]
2. Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy.
Zhu H; Leiss L; Yang N; Rygh CB; Mitra SS; Cheshier SH; Weissman IL; Huang B; Miletic H; Bjerkvig R; Enger PØ; Li X; Wang J
Oncotarget; 2017 Feb; 8(7):12145-12157. PubMed ID: 28076333
[TBL] [Abstract][Full Text] [Related]
3. Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells.
Candas-Green D; Xie B; Huang J; Fan M; Wang A; Menaa C; Zhang Y; Zhang L; Jing D; Azghadi S; Zhou W; Liu L; Jiang N; Li T; Gao T; Sweeney C; Shen R; Lin TY; Pan CX; Ozpiskin OM; Woloschak G; Grdina DJ; Vaughan AT; Wang JM; Xia S; Monjazeb AM; Murphy WJ; Sun LQ; Chen HW; Lam KS; Weichselbaum RR; Li JJ
Nat Commun; 2020 Sep; 11(1):4591. PubMed ID: 32929084
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma.
Ma D; Liu S; Lal B; Wei S; Wang S; Zhan D; Zhang H; Lee RS; Gao P; Lopez-Bertoni H; Ying M; Li JJ; Laterra J; Wilson MA; Xia S
Cancer Res; 2019 May; 79(10):2697-2708. PubMed ID: 30898840
[TBL] [Abstract][Full Text] [Related]
5. CPT1A/2-Mediated FAO Enhancement-A Metabolic Target in Radioresistant Breast Cancer.
Han S; Wei R; Zhang X; Jiang N; Fan M; Huang JH; Xie B; Zhang L; Miao W; Butler AC; Coleman MA; Vaughan AT; Wang Y; Chen HW; Liu J; Li JJ
Front Oncol; 2019; 9():1201. PubMed ID: 31803610
[TBL] [Abstract][Full Text] [Related]
6. EGFR-Induced and c-Src-Mediated CD47 Phosphorylation Inhibits TRIM21-Dependent Polyubiquitylation and Degradation of CD47 to Promote Tumor Immune Evasion.
Du L; Su Z; Wang S; Meng Y; Xiao F; Xu D; Li X; Qian X; Lee SB; Lee JH; Lu Z; Lyu J
Adv Sci (Weinh); 2023 Sep; 10(27):e2206380. PubMed ID: 37541303
[TBL] [Abstract][Full Text] [Related]
7. Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma.
Hutter G; Theruvath J; Graef CM; Zhang M; Schoen MK; Manz EM; Bennett ML; Olson A; Azad TD; Sinha R; Chan C; Assad Kahn S; Gholamin S; Wilson C; Grant G; He J; Weissman IL; Mitra SS; Cheshier SH
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):997-1006. PubMed ID: 30602457
[TBL] [Abstract][Full Text] [Related]
8. Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer.
Shimizu A; Sawada K; Kobayashi M; Yamamoto M; Yagi T; Kinose Y; Kodama M; Hashimoto K; Kimura T
Mol Cancer Res; 2021 Sep; 19(9):1583-1595. PubMed ID: 34016744
[TBL] [Abstract][Full Text] [Related]
9. AMPK-mediated CD47 H3K4 methylation promotes phagocytosis evasion of glioma stem cells post-radiotherapy.
Sun T; Liu B; Cao Y; Li Y; Cai L; Yang W
Cancer Lett; 2024 Feb; 583():216605. PubMed ID: 38218171
[TBL] [Abstract][Full Text] [Related]
10. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
[No Abstract] [Full Text] [Related]
11. Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma.
Zhang X; Chen W; Fan J; Wang S; Xian Z; Luan J; Li Y; Wang Y; Nan Y; Luo M; Li S; Tian W; Ju D
Carcinogenesis; 2018 May; 39(5):689-699. PubMed ID: 29538621
[TBL] [Abstract][Full Text] [Related]
12. LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization.
Hu J; Dong F; He Y; Xia X; Cheng F; Chen S; Hou X; Zhang P; Liu G; Li Y; Gao Q; Dong M; Li T; Li W; Xiao Q; Li X; Yu X; Xi G; Guo D; Wu X; Wang B
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096529
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis.
Hu J; Xiao Q; Dong M; Guo D; Wu X; Wang B
Front Immunol; 2020; 11():593219. PubMed ID: 33329583
[TBL] [Abstract][Full Text] [Related]
14. NDR1 activates CD47 transcription by increasing protein stability and nuclear location of ASCL1 to enhance cancer stem cell properties and evasion of phagocytosis in small cell lung cancer.
Wang LL; Wan XY; Wang TL; Liu CQ; Zheng FM
Med Oncol; 2022 Oct; 39(12):254. PubMed ID: 36224405
[TBL] [Abstract][Full Text] [Related]
15. Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells.
Xie B; Zhang L; Hu W; Fan M; Jiang N; Duan Y; Jing D; Xiao W; Fragoso RC; Lam KS; Sun LQ; Li JJ
Redox Biol; 2019 Jun; 24():101189. PubMed ID: 30986607
[TBL] [Abstract][Full Text] [Related]
16. The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a.
Peluso MO; Adam A; Armet CM; Zhang L; O'Connor RW; Lee BH; Lake AC; Normant E; Chappel SC; Hill JA; Palombella VJ; Holland PM; Paterson AM
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32345627
[TBL] [Abstract][Full Text] [Related]
17. Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.
Kuo TC; Chen A; Harrabi O; Sockolosky JT; Zhang A; Sangalang E; Doyle LV; Kauder SE; Fontaine D; Bollini S; Han B; Fu YX; Sim J; Pons J; Wan HI
J Hematol Oncol; 2020 Nov; 13(1):160. PubMed ID: 33256806
[TBL] [Abstract][Full Text] [Related]
18. Fatty Acids, CD36, Thrombospondin-1, and CD47 in Glioblastoma: Together and/or Separately?
Tanase C; Enciu AM; Codrici E; Popescu ID; Dudau M; Dobri AM; Pop S; Mihai S; Gheorghișan-Gălățeanu AA; Hinescu ME
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054787
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial glutamate transporter SLC25A22 uni-directionally export glutamate for metabolic rewiring in radioresistant glioblastoma.
Shin E; Kim B; Kang H; Lee H; Park J; Kang J; Park E; Jo S; Kim HY; Lee JS; Lee JM; Youn H; Youn B
Int J Biol Macromol; 2023 Dec; 253(Pt 8):127511. PubMed ID: 37866557
[TBL] [Abstract][Full Text] [Related]
20. Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres.
Shim JK; Choi S; Yoon SJ; Choi RJ; Park J; Lee EH; Cho HJ; Lee S; Teo WY; Moon JH; Kim HS; Kim EH; Cheong JH; Chang JH; Yook JI; Kang SG
Cancer Cell Int; 2022 Oct; 22(1):309. PubMed ID: 36221088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
